Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities (Q4670477)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities |
scientific article; zbMATH DE number 2160436
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities |
scientific article; zbMATH DE number 2160436 |
Statements
Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities (English)
0 references
22 April 2005
0 references
continual reassessment method
0 references
dose limiting
0 references
late-onset toxicities
0 references
likelihood-based design
0 references
phase I trial
0 references
time-to-event
0 references
0 references
0.8793752
0 references
0.8746122
0 references
0.87451804
0 references
0.8673604
0 references
0.86507744
0 references
